Pre-Clinical
Cell lines are convenient. They’re also why drugs fail. They don’t reflect tumor heterogeneity, microenvironment complexity, or patient-to-patient variation. Our pre-clinical capabilities test therapeutic hypotheses in the systems most likely to predict what will happen in patients: primary tissue from real tumors, with full molecular and clinical context attached.
Features
Evaluate therapies in human-relevant systems to surface risk, validate efficacy, and prioritize the right assets before clinical investment.
Target Validation & Primary Tissue Efficacy
Test whether your drug works in biology that resembles what it will encounter in patients. We run functional drug testing on primary patient tissue, including diseased and normal samples, to evaluate efficacy in human-relevant systems.
Every efficacy result comes paired with the clinical and molecular profile of the tissue it was tested in, so you know not just whether a drug works but in whom and why.
What your team gets: Efficacy data from human-relevant systems that predict clinical performance far more reliably than cell-line models, with built-in stratification signal.
The essential data layer for AI-driven medicine
Let’s build the evidence that moves your program forward.